SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-24-071014
Filing Date
2024-06-13
Accepted
2024-06-13 06:07:21
Documents
15
Period of Report
2024-06-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2417159d1_8ka.htm   iXBRL 8-K/A 30484
2 EXHIBIT 99.1 tm2417159d1_ex99-1.htm EX-99.1 36159
6 GRAPHIC tm2417159d1_ex99-1img001.jpg GRAPHIC 13676
  Complete submission text file 0001104659-24-071014.txt   269710

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sgmt-20240605.xsd EX-101.SCH 3012
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgmt-20240605_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgmt-20240605_pre.xml EX-101.PRE 22357
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2417159d1_8ka_htm.xml XML 3817
Mailing Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402
Business Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402 (650) 561-8600
Sagimet Biosciences Inc. (Filer) CIK: 0001400118 (see all company filings)

IRS No.: 205991472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-41742 | Film No.: 241039948
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)